X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (50) 50
hepatitis c, chronic - drug therapy (39) 39
gastroenterology & hepatology (33) 33
antiviral agents - therapeutic use (32) 32
recombinant proteins (29) 29
drug therapy, combination (27) 27
ribavirin - therapeutic use (27) 27
treatment outcome (27) 27
interferon-alpha - therapeutic use (26) 26
female (25) 25
male (25) 25
polyethylene glycols - therapeutic use (25) 25
hepacivirus - genetics (24) 24
hepatitis c (24) 24
ribavirin (24) 24
adult (22) 22
index medicus (21) 21
sustained virological response (21) 21
middle aged (20) 20
antiviral agents - administration & dosage (19) 19
hepatitis c, chronic - virology (19) 19
interferon (19) 19
genotype (18) 18
combination therapy (16) 16
plus ribavirin (16) 16
therapy (16) 16
hepacivirus - drug effects (15) 15
interferon-alpha - administration & dosage (15) 15
polyethylene glycols - administration & dosage (15) 15
ribavirin - administration & dosage (15) 15
40kd (14) 14
viral load (14) 14
pharmacology & pharmacy (13) 13
rna, viral - blood (13) 13
combination (12) 12
infection (12) 12
infectious diseases (12) 12
peginterferon-alpha-2a 40kd pegasys (12) 12
pegylated interferon (12) 12
interferon-alpha-2b plus ribavirin (11) 11
peginterferon alpha-2a (11) 11
treatment duration (11) 11
hepatitis c virus (10) 10
alpha-2b plus ribavirin (9) 9
chronic hepatitis-c (9) 9
hepatitis c - drug therapy (9) 9
peginterferon-alpha-2a 40kd (9) 9
viral kinetics (9) 9
virology (9) 9
40kd plus ribavirin (8) 8
care and treatment (8) 8
gastroenterology and hepatology (8) 8
management (8) 8
randomized controlled trials as topic (8) 8
retrospective studies (8) 8
time factors (8) 8
aged (7) 7
dose-response relationship, drug (7) 7
efficacy (7) 7
peginterferon alfa-2a (7) 7
randomized-trial (7) 7
recombinant proteins - therapeutic use (7) 7
ribavirin - adverse effects (7) 7
antiviral agents - adverse effects (6) 6
chronic hepatitis c (6) 6
clinical trials as topic (6) 6
drug administration schedule (6) 6
drug therapy (6) 6
health aspects (6) 6
hepacivirus - classification (6) 6
hepatitis (6) 6
hiv-infected patients (6) 6
human-immunodeficiency-virus (6) 6
pegylated interferon-alpha-2b (6) 6
treatment-naive patients (6) 6
virus-infection (6) 6
analysis (5) 5
anemia (5) 5
antiviral agents - pharmacokinetics (5) 5
follow-up studies (5) 5
genetic aspects (5) 5
hepacivirus - isolation & purification (5) 5
hepatitis c, chronic - blood (5) 5
initial treatment (5) 5
interferon-alpha - adverse effects (5) 5
medicine, general & internal (5) 5
pegylated interferon-alpha (5) 5
pharmacokinetics (5) 5
polyethylene glycols - adverse effects (5) 5
predictive value of tests (5) 5
prognosis (5) 5
randomized controlled-trial (5) 5
rapid virological response (5) 5
retreatment (5) 5
sustained virologic response (5) 5
virological response (5) 5
weight-based ribavirin (5) 5
alpha-2a (4) 4
antiviral agents - pharmacology (4) 4
antiviral therapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


GASTROENTEROLOGY, ISSN 0016-5085, 01/2010, Volume 138, Issue 1, pp. 108 - 115
BACKGROUND & AIMS: Ribavirin (RBV) combined with either pegylated interferon (PegIFN) alpha 2a or PegIFN alpha 2b is the standard of care for chronic hepatitis... 
SUSTAINED VIROLOGICAL RESPONSE | ALPHA-2A | TRIAL | INTERFERON-ALPHA-2B | VIRUS-INFECTION | MANAGEMENT | EFFICACY | PHARMACOKINETICS | GENOTYPE-1 | GASTROENTEROLOGY & HEPATOLOGY | 40KD
Journal Article
Journal Article
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2008, Volume 47, Issue 1, pp. 36 - 49
Journal Article
HEPATOLOGY RESEARCH, ISSN 1386-6346, 02/2014, Volume 44, Issue 2, pp. 179 - 186
AimRapid virological response (RVR), defined as serum hepatitis C virus (HCV) RNA negativity at 4 weeks, is the most useful predictor of sustained virological... 
DIAGNOSIS | ribavirin | MANAGEMENT | hepatitis C core antigen | 40KD | IMPACT | THERAPY | PEGINTERFERON ALPHA-2A | sustained virological response | pegylated interferon--2b | prediction | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION
Journal Article
Journal Article
Annals of Hepatology, ISSN 1665-2681, 2012, Volume 11, Issue 1, pp. 52 - 61
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2013, Volume 57, Issue 12, pp. 6097 - 6105
Journal Article
Liver International, ISSN 1478-3223, 01/2015, Volume 35, Issue 1, pp. 108 - 119
Journal Article
Journal Article